156 related articles for article (PubMed ID: 21832236)
1. Type 1 diabetes immunotherapy: is the glass half empty or half full?
Herold KC; Bluestone JA
Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
[TBL] [Abstract][Full Text] [Related]
2. Update on global intervention studies in type 1 diabetes.
Chiang JL; Haller MJ; Schatz DA
Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265
[TBL] [Abstract][Full Text] [Related]
3. [Antibodies instead of insulin?].
Anders S; Kühnemund L; Stauch M; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2010 Mar; 39(2):97-8. PubMed ID: 20196056
[No Abstract] [Full Text] [Related]
4. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
Boettler T; von Herrath M
Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
[TBL] [Abstract][Full Text] [Related]
5. [Current and future care for diabetes in children: from insulin to immunotherapy].
Dirlewanger M; Hauschild M; Phan-Hug F; Schwitzgebel VM
Rev Med Suisse; 2011 Feb; 7(283):430-6. PubMed ID: 21452510
[TBL] [Abstract][Full Text] [Related]
6. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
7. The year in immune intervention for type 1 diabetes.
Skyler JS
Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S88-95. PubMed ID: 23441712
[No Abstract] [Full Text] [Related]
8. [Immunotherapy of recent-onset type I diabetes mellitus].
Assan R
Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
[No Abstract] [Full Text] [Related]
9. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
Waldron-Lynch F; Herold KC
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
[TBL] [Abstract][Full Text] [Related]
10. Combination therapies for type 1 diabetes: why not now?
von Herrath M
Immunotherapy; 2010 May; 2(3):289-91. PubMed ID: 20635894
[No Abstract] [Full Text] [Related]
11. New orphan drug in the T1DM realm: another immunotherapy success story?
Dangi-Garimella S
Am J Manag Care; 2014 Mar; 20(4 Spec No.):E4. PubMed ID: 25618512
[No Abstract] [Full Text] [Related]
12. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Eldor R; Cohen IR; Raz I
Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
Phillips BE; Giannoukakis N; Trucco M
Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
[TBL] [Abstract][Full Text] [Related]
14. Insulin-dependent diabetes mellitus in adults.
Levandoski LA; Santiago JV
Curr Ther Endocrinol Metab; 1997; 6():418-30. PubMed ID: 9174784
[No Abstract] [Full Text] [Related]
15. Immunotherapy of insulin-dependent diabetes.
Bell DS; Acton RT
Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
[No Abstract] [Full Text] [Related]
16. [Could we cure type 1 diabetes by stimulating T(reg)?].
Grinberg-Bleyer Y; Baeyens A; Piaggio E; Salomon BL
Med Sci (Paris); 2011 May; 27(5):471-2. PubMed ID: 21609664
[No Abstract] [Full Text] [Related]
17. [Immunotherapy in type 1 (insulin-dependent) diabetes].
Galluzzo A
Recenti Prog Med; 1984 Oct; 75(10):936-43. PubMed ID: 6083588
[No Abstract] [Full Text] [Related]
18. Expanding immuno-therapies for type 1 diabetes.
Diabetes Obes Metab; 2000 Apr; 2(2):118. PubMed ID: 11220525
[No Abstract] [Full Text] [Related]
19. Diabetes mellitus in adults.
Saltman RJ; Orland MJ; Levin ME
Compr Ther; 1988 Sep; 14(9):55-64. PubMed ID: 3064962
[No Abstract] [Full Text] [Related]
20. Emergence of promising therapies in diabetes mellitus.
Akkati S; Sam KG; Tungha G
J Clin Pharmacol; 2011 Jun; 51(6):796-804. PubMed ID: 20705952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
